Clinical Trials in Chicago

Showing 11441-11460 of 20,493 trials

Study of Recombinant Factor IX Product, IB1001, in Previously Treated Pediatric Subjects With Hemophilia B

NCT01271868

The Study's Primary Objective is to evaluate the pharmacokinetics, safety (acute effects associated with infusions, and inhibitor development) and efficacy (breakthrough bleeding and control of hemorrhaging during prophylaxis) of IB1001 in previously treated pediatric subjects with hemophilia B.

Hemophilia B

Medexus Pharma, Inc.9 participantsStarted Nov 2010

Chicago, Illinois, United States • Indianapolis, Indiana, United States • Houston, Texas, United States +7 more locations

COMPLETEDPhase 12.2 miles

Impact of Botox Treatment Into the Upper One Third of the Face an Area on Mood and Self -Appearance Satisfaction

NCT04439825

Botox treatment into the upper one third of the face (glabella, forehead lines and/or lateral canthal lines) to analyze mood and self -appearance satisfaction in a Post Covid period on non-naïve Botox patients

Mood

DeNova Research45 participantsStarted Jul 2020

Chicago, Illinois, United States

COMPLETEDPhase 42.2 miles

KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)

NCT03236246

The objectives of this study are to assess the long-term efficacy and safety of different dose regimens of KRX-0502 in the treatment of iron deficiency anemia (IDA) in adult subjects with non-dialysis dependent chronic kidney disease (CKD).

Chronic Kidney DiseasesIron Deficiency Anemia

Keryx Biopharmaceuticals206 participantsStarted Aug 2017

Phoenix, Arizona, United States • Chula Vista, California, United States • El Centro, California, United States +25 more locations

Study of Recombinant Factor IX Product, IB1001, in Previously Treated Pediatric Subjects With Hemophilia B

Impact of Botox Treatment Into the Upper One Third of the Face an Area on Mood and Self -Appearance Satisfaction

KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)

Find Trials by Condition in Chicago

AMPLEX Ankle Fusion and Hindfoot

Selecting a Favorable KIR Donor in Unrelated HCT for AML

Teaching Skin Self -Examination to Melanoma Patients and Their Skin Check Partners

Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis

Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1

Effect of Multi-Media Tool on Enrollment in Oncology Clinical Trials

Adjunctive Ziprasidone in the Treatment of Bipolar I Depression

Facilitating Functional Independence in Patients Receiving Prolonged Mechanical Ventilation

Antibiotic Outbreak, Risk Factors for Never Event, Prediction of Inappropriate Use

Trial to Evaluate the Long-term Efficacy of Oral Aripiprazole in the Treatment of Pediatric Participants With Tourette's Disorder

Triggered Escalating Real-time Adherence (TERA) Intervention

A Study of Stress Echocardiography in Post-Menopausal Women at Risk for Coronary Disease

Algovita Spinal Cord Stimulation System Hi-Fi Study

Trinity™ BIOLOX Delta™ CoC THR Multi-center Study

A Controlled Trial of Losartan in Posttraumatic Stress Disorder

Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease

CBP501, Cisplatin and Nivolumab in Advanced Refractory Tumors